title: Allogenic BMT for multiple myeloma (MM). The Italian experience.
authors.affiliation: Inst. Haematology Seràgnoli, Bologna, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Cavo
authors.forename: S
authors.initials: S
authors.lastname: Tura
authors.forename: G
authors.initials: G
authors.lastname: Rosti
authors.forename: M
authors.initials: M
authors.lastname: Grimaldi
authors.forename: G
authors.initials: G
authors.lastname: Bandini
authors.forename: M A
authors.initials: MA
authors.lastname: Bonelli
authors.forename: E
authors.initials: E
authors.lastname: Calori
authors.forename: S
authors.initials: S
authors.lastname: Rizzi
authors.forename: M T
authors.initials: MT
authors.lastname: Van Lint
authors.forename: A
authors.initials: A
authors.lastname: Bacigalupo
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation / Q000401:mortality; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D010043:Outcome and Process Assessment, Health Care; D012074:Remission Induction; D014184:Transplantation, Homologous